Medgend Icon







discontinued


Benzaclin FDA Approved Drugs

ACANYA [Benzoyl PeroxideC14H10O4 : Clindamycin PhosphateC18H34ClN2O8PS]
RX
-
2.5% : eq 1.2% base (topical gel)
Dow PharmOct 23, 2008
  • Topical treatment of acne vulgaris in patients 12 years or older.
  • Topical treatment of acne vulgaris.
  • Treatment of acne vulgaris.
  • Treatment of acne.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

BENZACLIN [Benzoyl PeroxideC14H10O4 : Clindamycin PhosphateC18H34ClN2O8PS]
RX
-
5% : eq 1% base (topical gel)
Valeant BermudaDec 21, 2000
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE [Benzoyl PeroxideC14H10O4 : Clindamycin PhosphateC18H34ClN2O8PS]
RX
-
2.5% : eq 1.2% base (topical gel)
5% : 1.2% (topical gel)
5% : eq 1% base (topical gel)
Actavis Labs Ut IncJun 19, 2015
Perrigo IsraelJun 26, 2012
TolmarAug 25, 2016
Mylan Pharms IncAug 11, 2009
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DUAC [Benzoyl PeroxideC14H10O4 : Clindamycin PhosphateC18H34ClN2O8PS]
RX
-
5% : 1.2% (topical gel)
StiefelAug 26, 2002
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ONEXTON [Benzoyl PeroxideC14H10O4 : Clindamycin PhosphateC18H34ClN2O8PS]
RX
-
3.75% : eq 1.2% base (topical gel)
Dow PharmNov 24, 2014
  • Topical treatment of acne vulgaris in patients 12 years or older.
  • Topical treatment of acne vulgaris.
  • Treatment of acne vulgaris.
  • Treatment of acne.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.